RxDoctor Payments Data

Avnee Shah, MD

Dermatology · West Orange, NJNPI 1750600656

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,597 of the $10,778 with a category attached, or 89.0%. 36 manufacturers reported payments, led by AbbVie at 25.0% of the total.

$10,778in general payments, 2019–2025

Across 713 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • LEO Pharma Inc.$2K
  • Galderma Laboratories, L.p.$921
  • Pfizer$775
  • Sun Pharmaceutical Industries Inc.$500
  • Incyte Corporation$477
  • plus $3K from 30 others
$30,416in research payments, 2019–2025

Across 22 payments — averaging $1382.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sun Pharmaceutical Industries Inc.$27K
  • AbbVie$4K
  • E.r. Squibb & Sons, L.L.C.$61

What the payments were for

  • Consulting fees$1,10010%
  • Food & beverage$9,59789%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,778 in reported general payments places this provider in the 80th percentile of 394 dermatology providers in New Jersey.

See all dermatology providers in New Jersey

Medicare billing

Part B allowed, 2024
$100,345
Medicare patients
347
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab24$164,369
Cosentyx Sensoready (2 Pens)Secukinumab11$83,019
Clobetasol Propionate28$1,134
Ketoconazole54$908
Triamcinolone Acetonide47$471
Doxycycline Hyclate15$337
Ammonium Lactate21$272
Mupirocin24$155
Hydrocortisone38$152
Minocycline Hcl11$77

Paid to pharmacies, not to this prescriber.

Other dermatology in West Orange

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →